STRO logo

STRO Sutro Biopharma, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$8.60
-0.12 (-1.38%)

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free pr…

Market Cap: $142.77Mwww.sutrobio.com

Price

No data yet.

Social Signal Score

33
5d
—
30d
38
3 mentions
—
60d
31
4 mentions
—
90d
31
4 mentions
—
news: 4

Analyst Ratings

20 analysts
Buyconsensus
Strong Buy 0Buy 18Hold 1Sell 1Strong Sell 0
Avg price target$51.33+496.9%
Low $48Median $50High $56
Current Consensus

Revenue

$9.10M-39.75%
$4.04M$40.60M$77.16M$113.72M
Mar 2017Sep 2026

Analyst Estimates

FY2025
$-17.81
$-18.53–$-16.34
2 analysts
FY2026
$-8.12
$-9.39–$-6.20
7 analysts
FY2027
$-6.81
$-10.14–$-3.48
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jane Chung
Sector
Healthcare
Industry
Biotechnology
Employees
129
Beta
1.55
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-9.52
www.sutrobio.com